NASDAQ: EDITEditas Medicine Inc Stock Ownership - Who owns Editas Medicine?
Insider buying vs selling
Have Editas Medicine Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Linda Burkly | EVP CHIEF SCIENTIFIC OFFICER | 2025-06-03 | 726 | $1.72 | $1.25kSell |
| Amy Parison | SVP Chief Financial Officer | 2025-06-03 | 446 | $1.72 | $768.90Sell |
| Gilmore Neil Oneill | CEO | 2025-06-03 | 15,192 | $1.72 | $26.19kSell |
| Gilmore Neil Oneill | CEO | 2025-03-04 | 16,632 | $1.71 | $28.46kSell |
| Linda Burkly | EVP CHIEF SCIENTIFIC OFFICER | 2025-03-04 | 2,891 | $1.71 | $4.95kSell |
| Erick Lucera | EVP CHIEF FINANCIAL OFFICER | 2025-03-04 | 4,109 | $1.71 | $7.03kSell |
| Baisong Mei | EVP CHIEF MEDICAL OFFICER | 2024-12-03 | 541 | $2.08 | $1.12kSell |
| Gilmore Neil Oneill | CEO | 2024-12-03 | 1,618 | $2.08 | $3.36kSell |
| Baisong Mei | EVP CHIEF MEDICAL OFFICER | 2024-09-04 | 518 | $3.43 | $1.77kSell |
| Gilmore Neil Oneill | CEO | 2024-09-04 | 1,555 | $3.43 | $5.33kSell |
EDIT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when EDIT insiders and whales buy or sell their stock.
EDIT Shareholders
What type of owners hold Editas Medicine Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 8.92% | 7,466,254 | $14.71M | Institution |
| Blackrock Inc | 7.99% | 6,690,680 | $13.18M | Institution |
| Kevin P. Starr | 4.67% | 3,906,176 | $7.70M | Insider |
| Third Rock Ventures III LP | 4.67% | 3,906,176 | $7.70M | Insider |
| Polaris Venture Management Co VI LLC | 4.54% | 3,797,144 | $7.48M | Insider |
| Viking Global Investors LP | 3.58% | 2,996,590 | $5.90M | Insider |
| Kevin Bitterman | 3.34% | 2,797,144 | $5.51M | Insider |
| Flagship Ventures Fund IV LP | 3.33% | 2,786,967 | $5.49M | Insider |
| Boris Nikolic | 3.21% | 2,684,572 | $5.29M | Insider |
| Morgan Stanley | 3.18% | 2,658,921 | $5.24M | Institution |
EDIT vs Biotech Stocks
Editas Medicine Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.